Search results for "PROSPECTIVE COHORT"

showing 10 items of 1731 documents

Changes in Adrenoceptor and GRK Expression in Patients With Chronic Pulmonary Regurgitation.

2019

INTRODUCTION AND OBJECTIVES Pulmonary regurgitation (PR) is a frequent complication after repair of congenital heart disease. Lymphocyte expression of adrenoceptors (β1 and β2) and kinases (GRK2, GRK3, and GRK5) reflects the neurohumoral changes that occur in heart failure (HF). The main objective of this study was to describe the gene expression of these molecules in circulating lymphocytes in patients with severe PR. METHODS A prospective study was conducted to analyze lymphocyte expression of these molecules in patients with severe PR and compare it with expression in healthy controls and patients with advanced HF. RESULTS We studied 35 patients with severe PR, 22 healthy controls, and 1…

AdultMalemedicine.medical_specialtyHeart diseaseLymphocyteMagnetic Resonance Imaging Cine030204 cardiovascular system & hematologyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineGene expressionmedicineHumansProspective StudiesProspective cohort studybiologyKinasebusiness.industryBeta adrenergic receptor kinaseGeneral MedicineMiddle Agedmedicine.diseaseG-Protein-Coupled Receptor KinasesPulmonary Valve InsufficiencyReceptors Adrenergicmedicine.anatomical_structureGene Expression RegulationHeart failureChronic Diseasebiology.proteinRNAFemaleComplicationbusinessFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Diagnosis of culture-negative endocarditis: The role of the Duke criteria and the impact of transesophageal echocardiography

2001

Abstract Background The Duke criteria have been shown to be more sensitive than the von Reyn criteria in the diagnosis of culture-positive endocarditis but to date have not been fully validated for culture-negative endocarditis (CNE). The aim of this study was (1) to compare the diagnostic accuracy of the Duke criteria versus clinical judgment and the von Reyn criteria in CNE and (2) to assess the diagnostic impact of transesophageal echocardiography (TEE) on the Duke criteria in CNE. Methods The study group consisted of 49 patients with suspected CNE in whom the presence (n = 32) or absence (n = 17) of endocarditis was confirmed by surgery, autopsy, or both. All patients underwent transtho…

AdultMalemedicine.medical_specialtyHeart diseaseeducationNonbacterial thrombotic endocarditisSensitivity and SpecificityDuke criteriaDiagnosis DifferentialPredictive Value of Testsotorhinolaryngologic diseasesHumansMedicineEndocarditisProspective StudiesProspective cohort studyhealth care economics and organizationsAgedCulture-negative endocarditisChi-Square Distributionbusiness.industryEndocarditis BacterialMiddle Agedmedicine.diseasehumanitiesSurgerystomatognathic diseasesEchocardiographyPredictive value of testsFemaleRadiologyCardiology and Cardiovascular MedicinebusinessChi-squared distributionEchocardiography TransesophagealAmerican Heart Journal
researchProduct

Pegylated alpha-interferon-2a plus ribavirin compared with pegylated alpha-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C …

2008

Background and aim We assessed whether the two regimens of pegylated alpha-interferon-2b (PEG-IFN-alpha2b) plus ribavirin and pegylated alpha-interferon-2a (PEG-IFN-alpha2a) plus ribavirin showed differences in terms of sustained virological response, withdrawal due to side-effects and dose adjustment requirements in the treatment of naive chronic hepatitis C virus (HCV) patients. Methods A prospective non-randomized, open-label comparison was made of naive HCV-infected patients undergoing standard 24- or 48-week treatment with two PEG-IFN combined with weight-based dosing regimen of ribavirin (PEG-IFN-alpha2a/ribavirin, n = 91; PEG-IFN-alpha2b/ribavirin, n = 92). Results Sustained virologi…

AdultMalemedicine.medical_specialtyHepacivirusHepatitis C virusHepacivirusInterferon alpha-2medicine.disease_causeGastroenterologyAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundInterferonInternal medicineRibavirinmedicineHumansProspective StudiesProspective cohort studyHepatologymedicine.diagnostic_testbiologybusiness.industryRibavirinGastroenterologyInterferon-alphaHepatitis CHepatitis C ChronicMiddle AgedViral Loadbiology.organism_classificationmedicine.diseaseRecombinant ProteinsTreatment OutcomechemistryLiver biopsyImmunologyDrug Therapy CombinationFemalebusinessViral loadmedicine.drugJournal of gastroenterology and hepatology
researchProduct

Plasma PCSK9 is a late biomarker of severity in patients with severe trauma injury.

2013

PCSK9 (proprotein convertase subtilisin kexin type 9) is a secreted protease that modulates cholesterol homeostasis by decreasing low-density lipoprotein receptor expression. Low levels of plasma lipoproteins are related to severity of illness and survival in patients of intensive care units (ICU).The aim of the study was to investigate the regulation of plasma PCSK9 and its association with plasma lipid parameters and clinical markers of severity during critical illness.The plasma biobank from the previously published HYPOLYTE prospective study was used to measure PCSK9 concentrations by ELISA at days 0 and 8 in 111 patients admitted to surgical ICU for severe multiple trauma. Patients wer…

AdultMalemedicine.medical_specialtyHydrocortisoneEndocrinology Diabetes and MetabolismReceptor expressionCritical IllnessClinical BiochemistryContext (language use)PlaceboBiochemistryGastroenterologySeverity of Illness IndexPlacebosEndocrinologyIntensive careInternal medicineSeverity of illnessmedicineHumansProspective cohort studyInfusion PumpsHydrocortisoneTrauma Severity Indicesbusiness.industryPCSK9Biochemistry (medical)Serine EndopeptidasesCholesterol LDLPrognosisIntensive Care UnitsEndocrinologyImmunologyWounds and InjuriesFemaleProprotein ConvertasesProprotein Convertase 9businessBiomarkersmedicine.drugThe Journal of clinical endocrinology and metabolism
researchProduct

Development and application to clinical practice of a validated HPLC method for the analysis of β-glucocerebrosidase in Gaucher disease.

2014

The main objective of our study is to develop a simple, fast and reliable method for measuring ß-glucocerebrosidase activity in Gaucher patients leukocytes in clinical practice. This measurement may be a useful marker to drive dose selection and early clinical decision making of enzyme replacement therapy. We measure the enzyme activity by high-performance liquid chromatography with ultraviolet detection and 4-nitrophenyl-ß-d-glucopyranoside as substrate. A cohort of eight Gaucher patients treated with enzyme replacement therapy and ten healthy controls were tested; median enzyme activity values was 20.57mU/ml (interquartile range 19.92-21.53mU/ml) in patients and mean was 24.73mU/ml (24.12…

AdultMalemedicine.medical_specialtyImigluceraseAdolescentUltraviolet RaysClinical BiochemistryUrologyPharmaceutical ScienceAnalytical ChemistryInterquartile rangeDrug DiscoverymedicineLeukocytesHumansDosingProspective StudiesProspective cohort studyChildSpectroscopyEnzyme activity Gaucher disease HPLC Imiglucerase ß-GlucocerebrosidaseChromatography High Pressure LiquidGaucher DiseasebiologyChemistryEnzyme replacement therapyMiddle AgedEnzyme assayGlucosylceramidaseBiochemistrybiology.proteinGlucosylceramidaseFemaleGlucocerebrosidasemedicine.drugJournal of pharmaceutical and biomedical analysis
researchProduct

Use of buccal fat pad to repair post-extraction peri-implant bone defects in the posterior maxilla: a preliminary prospective study

2015

Background: Extensive literature exists about the use of the BFP in the treatment of oral defects but, to our knowledge, no article refers to the use of the BFP as a substitute of the membrane barriers for treatment of peri- implant bone defects. The aim was to evaluate the use of the buccal fat pad as a coating material for bone grafting in the peri-implant bone defect regeneration of immediate implants placed in the posterior maxilla. Material and Methods: A preliminary prospective study of patients involving immediate implants in which the buccal fat pad was used as a coating material to peri-implant bone defects was carried out. The outcome measures assessed were: postoperative pain and…

AdultMalemedicine.medical_specialtyImmediate Dental Implant Loadingmedicine.medical_treatmentAlveolar Bone LossDentistryOdontologíaBone graftingPeri implant bonemedicineHumansProspective StudiesProspective cohort studyGeneral DentistryAgedBuccal fat padBone Transplantationbusiness.industryWound dehiscenceResearchMean ageAlveolar Ridge AugmentationMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludSurgeryOtorhinolaryngologyAdipose TissueUNESCO::CIENCIAS MÉDICASSurgeryFemaleImplantOral SurgerybusinessPosterior maxilla
researchProduct

Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels--a study in twins.

2006

Elevated baseline levels of acute-phase proteins such as C-reactive protein (CRP) or cytokines like interleukin-6 (IL-6) are known risk factors for atherosclerosis and cardiovascular disease (CVD) events. However, until today, there is only controversial information about the contribution of genetic and environmental factors. Therefore, we performed an open prospective study in 108 monozygotic (MZ) and 60 same-sex dizygotic (DZ) twin pairs to analyse the genetic and environmental contributions to plasma CRP and IL-6 levels. Heritability of IL-6 was 0.61, indicating that plasma IL-6 levels are to a major part influenced by genetic determinants; however, for CRP, heritability was only 0.22, p…

AdultMalemedicine.medical_specialtyImmunologyInflammationDiseaseBiologyInternal medicineGeneticsmedicineTwins DizygoticHumansInterleukin 6Prospective cohort studyGenetics (clinical)InflammationInterleukin-6Twins MonozygoticHeritabilityMiddle AgedPlasma C-reactive proteinAtherosclerosisEndocrinologyC-Reactive ProteinCardiovascular DiseasesImmunologybiology.proteinFemalemedicine.symptomBody mass indexGenes and immunity
researchProduct

Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial.

2011

Objective To evaluate the efficacy and safety of an intraoral electrostimulation device, consisting of stimulating electrodes, an electronic circuit, and a power source, in treating xerostomia. The device delivers electrostimulation through the oral mucosa to the lingual nerve in order to enhance the salivary reflex. Methods The device was tested on a sample of patients with xerostomia due to Sjogren's syndrome and other sicca conditions in a 2-stage prospective, randomized, multicenter trial. Stage I was a double-blind, crossover stage designed to compare the effects of the electrically active device with the sham device, each used for 1 month, and stage II was a 3-month open-label stage d…

AdultMalemedicine.medical_specialtyImmunologySettore MED/50 - Scienze Tecniche Mediche ApplicateElectric Stimulation TherapySeverity of Illness IndexXerostomialaw.inventionRandomized controlled trialQuality of lifestomatognathic systemRheumatologyDouble-Blind MethodlawSettore MED/28 - Malattie OdontostomatologicheMulticenter trialSeverity of illnessotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansPharmacology (medical)Prospective StudiesOral mucosaProspective cohort studyAgedxerostomia; dry mouth; salivary gland hypofunction; saliva; electrical stimulation; electrostimulation; Sjögren’s syndromeIntention-to-treat analysisToxicitybusiness.industryMouth MucosaMiddle AgedDry mouthSurgeryOral cavityIntention to Treat Analysisstomatognathic diseasesmedicine.anatomical_structureSjogren's SyndromeTreatment OutcomeAnesthesiaFemalemedicine.symptombusinessArthritis and rheumatism
researchProduct

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

2014

This is the first prospective study of deferasirox in adult allogeneic hematopoietic stem cell transplant recipients with transfusional iron overload in hematologic malignancies. Patients at least six months post transplant were treated with deferasirox at a starting dose of 10 mg/kg/day for 52 weeks or until serum ferritin was less than 400 ng/mL on two consecutive occasions. Thirty patients were enrolled and 22 completed the study. A significant reduction from baseline in median serum ferritin and in liver iron concentration at 52 weeks was observed in the overall population: from 1440 to 755.5 ng/mL (P=0.002) and from 14.5 to 4.6 mg Fe/g dw (P=0.0007), respectively. Reduction in serum fe…

AdultMalemedicine.medical_specialtyLiver Iron ConcentrationIron Overloadmedicine.medical_treatmentPopulationStem cellsHematopoietic stem cell transplantationIron Chelating AgentsBenzoatesGastroenterologyYoung Adultchemistry.chemical_compoundInternal medicinemedicineHumansTransplantation HomologousAdverse effecteducationProspective cohort studyAgededucation.field_of_studyCreatininebusiness.industryDeferasiroxHematopoietic Stem Cell TransplantationHematologic diseasesTransfusion ReactionArticlesHematologyMiddle AgedTriazolesSurgeryTransplantationDeferasiroxTreatment OutcomechemistryMalalties hematològiquesFerritinsFemaleCèl·lules marebusinessmedicine.drug
researchProduct

Normal reference values of multilayer longitudinal strain according to age decades in a healthy population: A single-centre experience.

2017

Aims Recent advancements in echocardiographic technology allow to analyse myocardial strain in multiple layers. Little is known about the impact of age on layer-specific longitudinal strain in healthy subjects. The aim of this study was to analyse the influence of age on multilayer longitudinal strain and establish normal reference values of layer-specific strain according to age decades in a healthy population referring to our echo laboratory using 2D speckle-tracking echocardiography with layer-specific software. Methods and results Two-hundred sixty-six healthy, consecutive subjects (mean age = 39.2 ± 17.5 years, women/men = 137/129), free of cardiovascular risk factors, were enrolled. S…

AdultMalemedicine.medical_specialtyLongitudinal strain030204 cardiovascular system & hematologyVentricular Function LeftCohort Studies03 medical and health sciences0302 clinical medicineReference ValuesInternal medicineLinear regressionImage Interpretation Computer-AssistedmedicineHumansRadiology Nuclear Medicine and imaging030212 general & internal medicineProspective StudiesProspective cohort studyObserver VariationStrain (chemistry)business.industrysubendocardial strainConfoundingsubepicardial strainAge FactorsStroke VolumeGeneral MedicineMiddle AgedHealthy VolunteersageingAgeingEchocardiographyReference valuesCardiologyLinear ModelsFemaleCardiology and Cardiovascular Medicinebusinessglobal longitudinal strainglobal longitudinal strain subepicardial strain subendocardial strain echocardiography ageingCohort studyEuropean heart journal. Cardiovascular Imaging
researchProduct